Cargando…
Prospective randomized trial to compare the outcome and tolerability of delivering the same total dose of radiation in 61/2 weeks versus 51/2 weeks time in head and neck cancers
BACKGROUND: Concurrent chemoradiation is currently considered to be the standard of care in the treatment of head and neck cancer. In developing countries like ours, a good number of patients cannot tolerate chemoradiation because of the poor general condition and financial constraints. Those patien...
Autores principales: | Gupta, Manoj, Vats, Siddharth, Bhattacharyya, Tapesh, Seem, Rajeev K., Gupta, Manish, Mahajan, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756485/ https://www.ncbi.nlm.nih.gov/pubmed/26942141 http://dx.doi.org/10.4103/2278-330X.173168 |
Ejemplares similares
-
The impact of 2 weeks wait referral on survival of head and neck cancer patients
por: Rovira, Aleix, et al.
Publicado: (2023) -
Platysma myocutaneous flap revised in the free flaps era: clinical experience in 61 patients
por: Calabrese, Luca, et al.
Publicado: (2020) -
SEC61G identified as a prognostic biomarker of head and neck squamous cell carcinoma
por: Shi, Yanan, et al.
Publicado: (2021) -
Prophylactic exercises among head and neck cancer patients during and after swallowing sparing intensity modulated radiation: adherence and exercise performance levels of a 12-week guided home-based program
por: Cnossen, Ingrid C., et al.
Publicado: (2016) -
Peripheral osteoma, compound odontoma, focal cemento-osseous dysplasia, and cemento-ossifying fibroma in the same hemimandible: CBCT findings of an unusual case
por: Borghesi, Andrea, et al.
Publicado: (2017)